Ampicillin-sulbactam, ticarcillin-clavulanate, cefoxitin, cefotetan, and ceftizoxime are promoted for the treatment of mixed aerobic-anaerobic bacterial infections. Their activities have been compared in vitro but not in vivo. In order to assess the in vivo activities of these agents in serum and interstitial fluid, we administered single, intravenous doses of these antimicrobial agents to healthy subjects. Concentrations of the antimicrobial agents in serum and suction-induced blister fluid and bactericidal activity were measured by high-pressure liquid chromatography and the standard methodology of the National Committee for Clinical Laboratory Standards, respectively. The organisms used for bactericidal activity tests were one isolate each of Staphylococcus aureus, KiebsieUla pneumoniae, and Bacteroides fragilis. Pharmacokinetic parameters in serum and blister fluid were similar to those derived in other investigations. Of note were the high and prolonged concentrations of ticarcillin and cefotetan in blister fluid, despite high-level serum protein binding. The bactericidal activities in serum and blister fluid reflected the relative in vitro activities and kinetic dispositions of the various antimicrobial agents except for the bactericidal activity of cefotetan, which was substantially lower in blister fluid than serum, despite a blister fluid:serum area under the concentration-time curve ratio of 1.5. Similarly, the activity of ticarcillin-clavulanate in blister fluid was also substantially less than would have been predicted by the blister fluid:serum ratio of the area under the concentration-time curve of 1.1, possibly because of the low concentrations of clavulanate in blister fluid. The rankings of the in vivo bactericidal activities of the five drugs were as follows: for S. aureus, ampicillin-sulbactam > ticarcillin-clavulanate > ceftizoxime > cefoxitin > cefotetan; for K. pneumoniae, ceftizoxime > cefotetan > ampicillin-sulbactam = ticarcillin-clavulanate > cefoxitin; and for B. fragilis, ticarcillin-clavulanate > cefotetan > ceftizoxime > ampicillin-sulbactam = cefoxitin.
P-lactamase inhibitor renders these penicillins active against methicillin-susceptible staphylococci, Haemophilus influenzae, Bacteroides fragilis, most isolates of Klebsiella pneumoniae, and several other important bacterial pathogens (7, 13, 18) . Other agents with similar spectra of activity include cefoxitin, cefotetan, and ceftizoxime. All of these drugs are widely recommended for the treatment of mixed aerobicanaerobic bacterial infections. Their activities have been compared in vitro but seldom ex vivo, and their relative activities in extravascular fluids have not been assessed.
An increasingly used method for determination of extravascular penetration of antibiotics is the production of skin blisters by either cantharidin (inflammatory) or suction. These blisters contain fluid that is representative of so-called nonspecialized sites (5) . The capillary pores are the determining factor in penetration, and serum protein binding limits the penetration of most drugs into these sites (20) .
The purpose of this study, then, was to compare the pharmacokinetics, blister fluid penetration, and bactericidal activity in serum and blister fluid of the two ,B-lactamase inhibitor combinations as well as those of cefoxitin, cefotetan, and ceftizoxime in healthy subjects.
MATERIALS AND METHODS
Subjects. Six healthy male volunteers averaging 27 years in age (range, 21 to 31 years) and 74 kg in weight (range, 67 to 100 kg) were recruited to participate in the study. Each volunteer was examined, and laboratory tests were performed to determine that they were healthy. All subjects signed an informed consent form, and all phases of the investigation were carried out according to the rules and regulations of the Human Subjects Protection Committee, University of California, Los Angeles.
Blister formation. The formation of blisters was accomplished with negative pressure by a modification of a method described previously (16) . In brief, a blister-forming device was placed on the volar surface of the subject's forearm, and suction was applied for 1.5 to 2.0 h. This technique created 10 blisters that contained 80 to 125 ,ul of fluid per blister. Drug was administered within 5 min after the blisters were made. New blisters were created prior to each drug administration. Each drug administration was given in an alternate forearm.
Antibiotic dosage. Each subject received, as a single dose and in random order, ampicillin-sulbactam, 1 and 0.5 g, respectively; ticarcillin-clavulanate, 3 g and 0.1 g, respectively; and the three cephalosporins, 1 g each. These doses were chosen because they are considered appropriate for adults requiring treatment for soft tissue infections. All subjects had a 5 to 14-day washout period between each drug administration. The majority of all washout intervals was 7 days. All of the doses were diluted in normal saline and were administered as a 0.5-h constant-rate infusion into a forearm vein contralateral to the arm with the blisters. Sampling. Samples of serum and blister fluid for drug concentration and bactericidal activity determinations were taken at 1, 4, 6, and 8 h after the doses of ampicillinsulbactam, ticarcillin-clavulanate, and cefoxitin. Following administration of cefotetan and ceftizoxime, owing to their anticipated slower elimination, a 12-h serum sample was added, and the 6-h blister fluid sample was replaced with a 12-h sample. All serum and blister fluid samples were frozen at -70°C until assayed, which was generally not longer than 6 to 8 weeks.
Antibiotic assays. Ampicillin, ticarcillin, cefoxitin, and ceftizoxime concentrations in serum and blister fluid were assayed by high-pressure liquid chromatography by using modifications of methods described previously (2, 3, 9, 15). The lower detection limits for ampicillin, ticarcillin, cefoxitin, and ceftizoxime were all 0.3 ,ug/ml. Between-and within-day variation for all assays was <6%. Sulbactam and clavulanic acid concentrations were not measured.
The cefotetan assay was carried out in a manner similar to that for the other cephalosporins, with protein precipitation and extraction in acetonitrile and methylene chloride. Blister fluid was injected directly onto the column. Recovery was >90% 0.1 M phosphate buffer adjusted to pH 3.0. The column was a C18 ,uBondapak, and the detector was set at a 229-fl wavelength. The flow rate of the mobile phase was 2.0 ml/min, with a retention time of 6 min. The lower detection limit for cefotetan was 0.3 ,ug/ml. Inter-and intraday variations were found to be <6 and <10%, respectively. Bactericidal activity. Standardized methods were used for determining serum bactericidal activity and were modified to determine blister fluid activity (17) . Briefly, quality-controlled, complement-inactivated pooled human serum was used to serially dilute patient samples by a microdilution method. The addition of pooled human serum would decrease the amount of free antibiotic available to assert bactericidal activity. This could affect antibacterial results for agents known to have high-level protein binding. The aerobic and anaerobic test isolates used in this study are described in Table 1 . These isolates were selected because of their production of P-lactamase and their susceptibilities to the antimicrobial agents studied. The Staphylococcus aureus and K pneumoniae inocula were prepared in cation-supplemented Mueller-Hinton broth. Vitamin K-and hemin-supplemented brain heart infusion broth was chosen for use in preparation of the B. fragilis inoculum. All inocula were standardized to deliver 3 x 104 to 6 x 104 CFU/50 ,ul. The actual number of organisms inoculated into each well was verified. Serum samples were tested by using 50 pl per test, while blister fluid samples were tested with a 30 ,ul-volume. Equal volumes of inoculum were added to each sample or pooled human serum control microdilution well. For S. aureus and K pneumoniae, microdilution trays were incubated at 37°C for 20 to 24 h under aerobic conditions, while the B. fragilis trays were incubated for 44 to 48 h under anaerobic conditions in GasPak jars. In order to determine bactericidal activities, all wells showing inhibition of growth at the end of the incubation period were subcultured (10 pl) onto a blood agar plate. Bactericidal activity was recorded after 24 to 48 h of incubation under conditions similar to those described above. The bactericidal end point was defined as >3-log-unit killing of the samples being tested once (14) . Samples were analyzed within 5 weeks of the study day. Both serum and blister fluid samples were tested at the same time for each subject for each antibiotic. This ensured an identical inoculum size for all antibiotics tested for that subject.
Pharmacokinetic analysis. The elimination rate constant was estimated by weighted, nonlinear regression analysis of the last three to four datum points on the serum or blister fluid concentration-versus-time curve. The half-life was calculated by dividing the natural logarithm of two by the elimination rate constant. Areas under the serum and blister fluid concentration-versus-time curves (AUCs) from 1 to 8 (or 1 to 12) h were evaluated by using the trapezoidal rule. Bactericidal titers against each organism for each time point in serum and blister fluid were used to calculate the area under the bactericidal titer-versus-time curve (AUBC) by applying the trapezoidal rule to a plot of the serum or blister fluid bactericidal titers over time (1) . The mean AUBCs for each organism in serum and blister fluid were then calculated.
Statistical analysis. Differences in AUBCs between and among the five study drugs were calculated by analysis of variance for repeated measures. The comparison test was Fisher LSD. A P value of 0.01 was considered significant. Table 2 details the concentrations of the five beta-lactams in serum and blister fluid following a single intravenous dose. The elimination half-lives of ampicillin and ticarcillin were tions both in serum and in blister fluid (4) . The explanation slower (half-life, 2.6 h). We have no explanation for this for this observation is unknown.
RESULTS
discrepancy. However, we were surprised at the high and The penetration of cefoxitin into cantharidin-induced blisprolonged concentrations of ticarcllin in blister fluid. In ters after a 1-g intramuscular injection was assessed by Wise contrast to the cephalosporins tested, in which the eliminaet al. (20) . Those investigators found a half-life of elimination tion from blister fluid was only 1.1 to 1.6 times slower than from blister fluid of 1.3 h, a maximum concentration in that from serum, the half-life of penicillin in blister fluid was blister fluid of 11.5 mg/liter, and an AUC in blister fluid of 36 1.96 to 2.2 times that found in serum.
mg. h/liter from 0 to 6 h. These values are greater than those
In general, our results indicate that all of the drugs observed and estimated in our study, possibly because of penetrated well into blister fluid, with concentrations exdifferences in sampling schedules and the blister formation ceeding those found in serum for much of the 8-to 12-h time technique.
period. Despite the relatively high serum protein binding of Cefotetan was given as a 1-g intramuscular injection to cefotetan (ca. 85%), we found excellent penetration into healthy subjects after suction-induced blisters were formed blister fluid. Our data are in agreement with those of Bergan (18) . Those investigators (18) found a peak concentration in and colleagues (5), who demonstrated that high serum problister fluid of only 12.5 mg/liter. This is far lower than the tein binding does not inhibit the penetration of most antibiconcentrations observed and the peak concentration in blis-otics into extravascular spaces. ter fluid predicted in our study. The reason for the aberration The bactericidal activities in serum and blister fluid reis unclear, but it may be due to a variation in the method of flected the antibiotic penetration characteristics and the administration, subject variation, or the method of suction activities of the drugs in vitro. We selected one gramblister formation.
positive aerobe, one gram-negative aerobe, and one-gram Finally, the only other of our study antibiotics that has negative anaerobe for bactericidal activity testing. The spebeen assessed in a similar fashion is ticarcillin and clavulanic cific isolates were chosen for the representative nature of acid. Bennett et al. gave a 3.2-g dose of ticarcillin-clavueach organism for the described bacterial group. In order to lanate to healthy subjects after induction of cantharidinreduce the risk of biasing our results, we would have induced blisters. They found that the maximum concentra-preferred to test more than one strain in each group. Unfortion in blister fluid (115 mg/liter) occurred at 1.75 h and that tunately, because of serum and especially blister fluid quanthe elimination from blister fluid had a half-life of 1.3 h. tity limitations, this could not have been done. Those data are consistent with ours, except for our obserAgainst the isolate of S. aureus (Table 4) , the ,B-lactamase vation that the elimination from blister fluid was much inhibitor combinations produced the best activity both in serum and in blister fluid. This is consistent with the in vitro activity, data from experimental infections, and clinical experience that suggest that these drugs are excellent antistaphylococcal agents (8) . Despite concentrations of cefotetan in the intravascular space and blister fluid that were profoundly above the MIC of 8.0 p,g/ml for S. aureus, cefotetan had relatively poor in vitro activity in both of these compartments. This may be due to cefotetan's relatively high level of protein binding, leading to less of an ex vivo effect. The activity of cefoxitin was also poor given the relatively low concentrations of the drug in serum and blister fluid and the intermediate activity of the drug against the staphylococcal isolate. Against the isolate of K pneumoniae (Table 5) , the superior in vitro activities of ceftizoxime and cefotetan were reflected in the very high and prolonged activities in serum and, in the case of ceftizoxime, activity in blister fluid.
Cefoxitin and the P-lactamase inhibitor combinations produced low-level bactericidal activity in serum and blister fluid for 8 h. The exact nature of the prominent decrease in cefotetan activity in blister fluid is unknown. Among the factors that contribute to this decrease in activity is probably high-level protein binding.
Finally, the isolate of B. fragilis was killed significantly better by ticarcillin-clavulanate and cefotetan in serum and by ticarcillin-clavulanate in blister fluid (Table 6 ). Ticarcillinclavulanate activity was superior in blister fluid probably because of the larger administered dose. Ceftizoxime was also superior to both ampicillin-sulbactam and cefoxitin, owing to its excellent activity and penetration into tissue. Despite the low concentrations of ceftizoxime in blister fluid, we observed median bactericidal titers of 4 at all of the sampling times. This result is in contrast to what would be expected from our concentration results. Although we are unsure of the cause for this observation, this incident may be due to a heat-stable peptide that enhances the activities of antibiotics against gram-negative bacteria (12) .
Of note is the dramatic difference in activity of cefotetan between serum and blister fluid. Against the isolates tested, the ratio of blister fluid activity:serum activity of cefotetan ranged from approximately 0.02 to 0.27 (mean ± standard deviation, 0.11 + 0.14). This may be due to the presence of albumin and other proteins in serum to which cefotetan is highly bound (free fraction, ca. 0.15). Binding to intravascular proteins would lead to less drug available for diffusion into the suction blisters. We did not assess the binding of cefotetan in blister fluid, but since it is known that proteins are present in blister fluid, this is a possible explanation for the discrepancy in activity. (11) .
In summary, we compared the kinetics, tissue fluid penetrations, and bactericidal activities of five beta-lactams with broad spectra of activity. The antibiotics tested were selected because of their widespread use against mixed infections, and the organisms were chosen as examples of bacteria commonly seen in mixed aerobic-anaerobic infections such as intra-abdominal sepsis or soft tissue infections. Overall, the drugs produced good bactericidal activity against the test strains for at least 6 h, and in the case of ceftizoxime and cefotetan, bactericidal activity was good for 12 h. Analysis of the relative activities of the drugs revealed that ampicillin-sulbactam produced the best activity against S. aureus, ceftizoxime produced the best activity against K pneumoniae, and ticarcillin-clavulanate produced the best activity against B. fragilis.
